Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
283M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
218M
-
Shares change
-
-6.1M
-
Total reported value, excl. options
-
$277M
-
Value change
-
-$8.2M
-
Put/Call ratio
-
0
-
Number of buys
-
83
-
Number of sells
-
-71
-
Price
-
$1.27
Significant Holders of Erasca, Inc. - Common Stock (ERAS) as of Q2 2025
179 filings reported holding ERAS - Erasca, Inc. - Common Stock as of Q2 2025.
Erasca, Inc. - Common Stock (ERAS) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 218M shares
of 283M outstanding shares and own 77% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (22.7M shares), T. Rowe Price Investment Management, Inc. (20.3M shares), VR ADVISER, LLC (17.9M shares), BlackRock, Inc. (15.2M shares), Logos Global Management LP (15M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (14.5M shares), VANGUARD GROUP INC (12.7M shares), Paradigm Biocapital Advisors LP (11.9M shares), ARCH Venture Management, LLC (11.1M shares), and Siren, L.L.C. (8.76M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.